Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

Alectinib, a novel alternative anaplastic lymphoma kinase (ALK) inhibitor, is highly effective against ALK-positive non-small cell lung cancer (NSCLC) and is well tolerated. Molecular targeted agents generally have little contribution to alopecia. We encountered a case of alopecia that developed gra...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Case Rep Oncol
Glavni autori: Koizumi, Tomonobu, Fukushima, Toshirou, Gomi, Daisuke, Kobayashi, Takashi, Sekiguchi, Nodoka, Sakamoto, Akiyuki, Sasaki, Shigeru, Mamiya, Keiko
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2016
Teme:
Published online: April, 2016
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868938/
https://ncbi.nlm.nih.gov/pubmed/27194980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000445288
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items